Cancer nanotechnology: Enhancing tumor cell response to chemotherapy for hepatocellular carcinoma therapy

• Main Authors: Yongbing Sun (Author), Wen Ma (Author), Yuanyuan Yang (Author), Mengxue He (Author), Aimin Li (Author), Lei Bai (Author), Bin Yu (Author), Zhiqiang Yu (Author)
• Format: Book
• Published: Elsevier, 2019-11-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Hepatocellular carcinoma (HCC) is one of the deadliest cancers due to its complexities, reoccurrence after surgical resection, metastasis and heterogeneity. In addition to sorafenib and lenvatinib for the treatment of HCC approved by FDA, various strategies including transarterial chemoembolization,...